Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 33 |
NetGPI | no | yes: 0, no: 34 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 17 |
GO:0110165 | cellular anatomical entity | 1 | 19 |
GO:0005737 | cytoplasm | 2 | 2 |
GO:0005739 | mitochondrion | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: A0A3S5H7D5
Term | Name | Level | Count |
---|---|---|---|
GO:0006082 | organic acid metabolic process | 3 | 1 |
GO:0006629 | lipid metabolic process | 3 | 1 |
GO:0006631 | fatty acid metabolic process | 4 | 1 |
GO:0006633 | fatty acid biosynthetic process | 5 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0008610 | lipid biosynthetic process | 4 | 1 |
GO:0009058 | biosynthetic process | 2 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016053 | organic acid biosynthetic process | 4 | 1 |
GO:0019752 | carboxylic acid metabolic process | 5 | 1 |
GO:0030497 | fatty acid elongation | 6 | 1 |
GO:0032787 | monocarboxylic acid metabolic process | 6 | 1 |
GO:0043436 | oxoacid metabolic process | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044249 | cellular biosynthetic process | 3 | 1 |
GO:0044255 | cellular lipid metabolic process | 3 | 1 |
GO:0044281 | small molecule metabolic process | 2 | 1 |
GO:0044283 | small molecule biosynthetic process | 3 | 1 |
GO:0046394 | carboxylic acid biosynthetic process | 5 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0072330 | monocarboxylic acid biosynthetic process | 6 | 1 |
GO:1901576 | organic substance biosynthetic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 4 |
GO:0004312 | fatty acid synthase activity | 5 | 4 |
GO:0004316 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity | 5 | 4 |
GO:0016491 | oxidoreductase activity | 2 | 4 |
GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | 3 | 4 |
GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 4 | 4 |
GO:0016740 | transferase activity | 2 | 4 |
GO:0016746 | acyltransferase activity | 3 | 4 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 4 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_MEL_PAP_1 | 183 | 189 | PF00089 | 0.280 |
CLV_NRD_NRD_1 | 301 | 303 | PF00675 | 0.568 |
CLV_NRD_NRD_1 | 308 | 310 | PF00675 | 0.538 |
CLV_NRD_NRD_1 | 75 | 77 | PF00675 | 0.385 |
CLV_PCSK_KEX2_1 | 159 | 161 | PF00082 | 0.276 |
CLV_PCSK_KEX2_1 | 308 | 310 | PF00082 | 0.556 |
CLV_PCSK_KEX2_1 | 75 | 77 | PF00082 | 0.410 |
CLV_PCSK_PC1ET2_1 | 159 | 161 | PF00082 | 0.304 |
CLV_PCSK_PC7_1 | 155 | 161 | PF00082 | 0.278 |
CLV_PCSK_SKI1_1 | 181 | 185 | PF00082 | 0.351 |
CLV_PCSK_SKI1_1 | 279 | 283 | PF00082 | 0.554 |
CLV_PCSK_SKI1_1 | 81 | 85 | PF00082 | 0.379 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.559 |
DOC_CKS1_1 | 296 | 301 | PF01111 | 0.738 |
DOC_MAPK_HePTP_8 | 183 | 195 | PF00069 | 0.402 |
DOC_MAPK_MEF2A_6 | 186 | 195 | PF00069 | 0.462 |
DOC_PP4_FxxP_1 | 197 | 200 | PF00568 | 0.509 |
DOC_USP7_MATH_1 | 133 | 137 | PF00917 | 0.506 |
DOC_USP7_MATH_1 | 161 | 165 | PF00917 | 0.511 |
DOC_USP7_MATH_1 | 273 | 277 | PF00917 | 0.522 |
DOC_USP7_MATH_1 | 280 | 284 | PF00917 | 0.628 |
DOC_USP7_MATH_1 | 319 | 323 | PF00917 | 0.744 |
DOC_USP7_UBL2_3 | 434 | 438 | PF12436 | 0.381 |
DOC_WW_Pin1_4 | 116 | 121 | PF00397 | 0.602 |
DOC_WW_Pin1_4 | 242 | 247 | PF00397 | 0.590 |
DOC_WW_Pin1_4 | 295 | 300 | PF00397 | 0.762 |
DOC_WW_Pin1_4 | 345 | 350 | PF00397 | 0.533 |
DOC_WW_Pin1_4 | 357 | 362 | PF00397 | 0.552 |
LIG_14-3-3_CanoR_1 | 18 | 22 | PF00244 | 0.662 |
LIG_14-3-3_CanoR_1 | 288 | 292 | PF00244 | 0.697 |
LIG_14-3-3_CanoR_1 | 3 | 8 | PF00244 | 0.766 |
LIG_14-3-3_CanoR_1 | 341 | 349 | PF00244 | 0.504 |
LIG_BRCT_BRCA1_1 | 358 | 362 | PF00533 | 0.640 |
LIG_CSL_BTD_1 | 243 | 246 | PF09270 | 0.598 |
LIG_eIF4E_1 | 370 | 376 | PF01652 | 0.306 |
LIG_FHA_1 | 18 | 24 | PF00498 | 0.580 |
LIG_FHA_1 | 202 | 208 | PF00498 | 0.465 |
LIG_FHA_1 | 331 | 337 | PF00498 | 0.698 |
LIG_FHA_1 | 78 | 84 | PF00498 | 0.607 |
LIG_FHA_1 | 92 | 98 | PF00498 | 0.479 |
LIG_FHA_2 | 377 | 383 | PF00498 | 0.334 |
LIG_HCF-1_HBM_1 | 11 | 14 | PF13415 | 0.617 |
LIG_LIR_Apic_2 | 276 | 280 | PF02991 | 0.666 |
LIG_LIR_Gen_1 | 149 | 157 | PF02991 | 0.485 |
LIG_LIR_Gen_1 | 20 | 29 | PF02991 | 0.569 |
LIG_LIR_Gen_1 | 363 | 374 | PF02991 | 0.416 |
LIG_LIR_Nem_3 | 149 | 154 | PF02991 | 0.462 |
LIG_LIR_Nem_3 | 250 | 255 | PF02991 | 0.595 |
LIG_LIR_Nem_3 | 363 | 369 | PF02991 | 0.372 |
LIG_Pex14_2 | 362 | 366 | PF04695 | 0.459 |
LIG_PTB_Apo_2 | 395 | 402 | PF02174 | 0.315 |
LIG_PTB_Phospho_1 | 395 | 401 | PF10480 | 0.317 |
LIG_RPA_C_Fungi | 64 | 76 | PF08784 | 0.501 |
LIG_SH2_GRB2like | 402 | 405 | PF00017 | 0.359 |
LIG_SH2_PTP2 | 373 | 376 | PF00017 | 0.484 |
LIG_SH2_SRC | 371 | 374 | PF00017 | 0.240 |
LIG_SH2_SRC | 407 | 410 | PF00017 | 0.472 |
LIG_SH2_STAP1 | 312 | 316 | PF00017 | 0.624 |
LIG_SH2_STAT5 | 128 | 131 | PF00017 | 0.303 |
LIG_SH2_STAT5 | 157 | 160 | PF00017 | 0.368 |
LIG_SH2_STAT5 | 182 | 185 | PF00017 | 0.220 |
LIG_SH2_STAT5 | 201 | 204 | PF00017 | 0.370 |
LIG_SH2_STAT5 | 220 | 223 | PF00017 | 0.349 |
LIG_SH2_STAT5 | 237 | 240 | PF00017 | 0.456 |
LIG_SH2_STAT5 | 368 | 371 | PF00017 | 0.306 |
LIG_SH2_STAT5 | 373 | 376 | PF00017 | 0.284 |
LIG_SH2_STAT5 | 41 | 44 | PF00017 | 0.386 |
LIG_SH3_3 | 240 | 246 | PF00018 | 0.531 |
LIG_SH3_3 | 44 | 50 | PF00018 | 0.440 |
LIG_SUMO_SIM_anti_2 | 111 | 116 | PF11976 | 0.386 |
LIG_SUMO_SIM_anti_2 | 167 | 172 | PF11976 | 0.348 |
LIG_TYR_ITIM | 369 | 374 | PF00017 | 0.346 |
MOD_CDK_SPK_2 | 242 | 247 | PF00069 | 0.500 |
MOD_CDK_SPxxK_3 | 295 | 302 | PF00069 | 0.752 |
MOD_CK1_1 | 164 | 170 | PF00069 | 0.450 |
MOD_CK1_1 | 283 | 289 | PF00069 | 0.547 |
MOD_CK1_1 | 307 | 313 | PF00069 | 0.620 |
MOD_CK1_1 | 322 | 328 | PF00069 | 0.676 |
MOD_CK2_1 | 3 | 9 | PF00069 | 0.631 |
MOD_CK2_1 | 322 | 328 | PF00069 | 0.699 |
MOD_CK2_1 | 376 | 382 | PF00069 | 0.406 |
MOD_Cter_Amidation | 300 | 303 | PF01082 | 0.658 |
MOD_Cter_Amidation | 73 | 76 | PF01082 | 0.525 |
MOD_GlcNHglycan | 223 | 226 | PF01048 | 0.238 |
MOD_GlcNHglycan | 238 | 241 | PF01048 | 0.564 |
MOD_GlcNHglycan | 309 | 312 | PF01048 | 0.639 |
MOD_GlcNHglycan | 324 | 327 | PF01048 | 0.620 |
MOD_GlcNHglycan | 362 | 365 | PF01048 | 0.401 |
MOD_GlcNHglycan | 47 | 50 | PF01048 | 0.470 |
MOD_GlcNHglycan | 94 | 97 | PF01048 | 0.338 |
MOD_GSK3_1 | 280 | 287 | PF00069 | 0.623 |
MOD_GSK3_1 | 356 | 363 | PF00069 | 0.458 |
MOD_GSK3_1 | 41 | 48 | PF00069 | 0.434 |
MOD_GSK3_1 | 77 | 84 | PF00069 | 0.536 |
MOD_GSK3_1 | 88 | 95 | PF00069 | 0.317 |
MOD_N-GLC_1 | 164 | 169 | PF02516 | 0.495 |
MOD_N-GLC_2 | 389 | 391 | PF02516 | 0.336 |
MOD_N-GLC_2 | 77 | 79 | PF02516 | 0.338 |
MOD_NEK2_1 | 24 | 29 | PF00069 | 0.492 |
MOD_NEK2_1 | 356 | 361 | PF00069 | 0.455 |
MOD_NEK2_1 | 362 | 367 | PF00069 | 0.328 |
MOD_NEK2_1 | 412 | 417 | PF00069 | 0.541 |
MOD_NEK2_1 | 65 | 70 | PF00069 | 0.418 |
MOD_PIKK_1 | 319 | 325 | PF00454 | 0.705 |
MOD_PIKK_1 | 381 | 387 | PF00454 | 0.322 |
MOD_PKA_2 | 161 | 167 | PF00069 | 0.365 |
MOD_PKA_2 | 17 | 23 | PF00069 | 0.514 |
MOD_PKA_2 | 24 | 30 | PF00069 | 0.317 |
MOD_PKA_2 | 287 | 293 | PF00069 | 0.628 |
MOD_PKA_2 | 307 | 313 | PF00069 | 0.661 |
MOD_PKA_2 | 340 | 346 | PF00069 | 0.391 |
MOD_PKA_2 | 77 | 83 | PF00069 | 0.482 |
MOD_Plk_1 | 110 | 116 | PF00069 | 0.332 |
MOD_Plk_1 | 164 | 170 | PF00069 | 0.425 |
MOD_Plk_4 | 233 | 239 | PF00069 | 0.507 |
MOD_Plk_4 | 24 | 30 | PF00069 | 0.370 |
MOD_Plk_4 | 3 | 9 | PF00069 | 0.612 |
MOD_Plk_4 | 362 | 368 | PF00069 | 0.406 |
MOD_Plk_4 | 383 | 389 | PF00069 | 0.334 |
MOD_Plk_4 | 424 | 430 | PF00069 | 0.299 |
MOD_ProDKin_1 | 116 | 122 | PF00069 | 0.501 |
MOD_ProDKin_1 | 242 | 248 | PF00069 | 0.484 |
MOD_ProDKin_1 | 295 | 301 | PF00069 | 0.727 |
MOD_ProDKin_1 | 345 | 351 | PF00069 | 0.413 |
MOD_ProDKin_1 | 357 | 363 | PF00069 | 0.428 |
MOD_SUMO_for_1 | 437 | 440 | PF00179 | 0.509 |
TRG_ENDOCYTIC_2 | 371 | 374 | PF00928 | 0.367 |
TRG_ER_diArg_1 | 75 | 78 | PF00400 | 0.402 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P2S7 | Leptomonas seymouri | 33% | 86% |
A0A0N1HZ81 | Leptomonas seymouri | 70% | 79% |
A0A0N1I1M5 | Leptomonas seymouri | 23% | 89% |
A0A0S4IWT0 | Bodo saltans | 33% | 94% |
A0A0S4IZG2 | Bodo saltans | 35% | 97% |
A0A0S4J1I6 | Bodo saltans | 43% | 100% |
A0A1X0NVT8 | Trypanosomatidae | 36% | 88% |
A0A1X0NVV6 | Trypanosomatidae | 52% | 86% |
A0A3Q8ID46 | Leishmania donovani | 34% | 100% |
A0A3Q8IM89 | Leishmania donovani | 28% | 100% |
A0A3R7K071 | Trypanosoma rangeli | 52% | 91% |
A0A3S7X986 | Leishmania donovani | 24% | 91% |
A0A422N2B6 | Trypanosoma rangeli | 35% | 92% |
A4HDP2 | Leishmania braziliensis | 86% | 100% |
A4HDP3 | Leishmania braziliensis | 32% | 98% |
A4HMN7 | Leishmania braziliensis | 27% | 100% |
A4HMN9 | Leishmania braziliensis | 24% | 100% |
C9ZWC0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 33% | 93% |
C9ZWC1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 52% | 88% |
C9ZZF1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 100% |
E9AF41 | Leishmania major | 23% | 100% |
E9AH88 | Leishmania infantum | 99% | 100% |
E9AH89 | Leishmania infantum | 33% | 100% |
E9AHV6 | Leishmania infantum | 28% | 100% |
E9AHV8 | Leishmania infantum | 24% | 100% |
E9AX26 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
E9AX27 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 33% | 100% |
E9B694 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 29% | 100% |
E9B696 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 24% | 100% |
Q4QAE9 | Leishmania major | 34% | 100% |
Q4QAF0 | Leishmania major | 93% | 100% |
V5BAF4 | Trypanosoma cruzi | 35% | 92% |
V5BNY6 | Trypanosoma cruzi | 28% | 100% |